Cover Image
市場調查報告書

Dydrogesterone的中國市場

Investigation Report on China Dydrogesterone Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 338984
出版日期 內容資訊 英文 20 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Dydrogesterone的中國市場 Investigation Report on China Dydrogesterone Market, 2010-2019
出版日期: 2015年09月07日 內容資訊: 英文 20 Pages
簡介

Dydrogesterone作為新世代的孕甾酮,1961年由Abbott Biologicals B. V. (荷蘭) 開發,之後在全球150個國家的市場上市。中國2004年4月也獲認證。調查對象醫院的Dydrogesterone的銷售額,從2005年的400萬人民幣,到2014年的1億人民幣以上,以年複合成長率(CAGR)50%速度急速擴大。現在雖然只能由Abbott Biologicals B.V.供給產品,不過,由於中國國內不孕症的問題變得嚴重,及新加入企業的登場,今後預期將進一步成長。

本報告提供中國的Dydrogesterone的市場相關分析、關於Dydrogesterone的特徵和認證情形、市場整體規模、各企業、各劑型的市場佔有率、價格趨勢、主要製造商簡介、今後的市場成長預測等的調查評估。

第1章 Dydrogesterone的相關概念

  • 適應症
  • 全球市場的銷售情形

第2章 中國的Dydrogesterone市場簡介

  • 中國國內的Dydrogesterone的專利申請、核準情況
  • 主要製造商
  • 市場規模

第3章 中國國內的Dydrogesterone銷售額分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 Dydrogesterone的主要廠商的市場佔有率 (過去5年份)

  • 市場佔有率 (以金額為準)
  • 市場佔有率 (以數量為準)

第5章 中國國內的Dydrogesterone的劑型 (過去5年份)

  • 各劑型的市場佔有率 (以金額為準)
  • 各劑型的市場佔有率 (以數量為準)

第6章 中國醫院的Dydrogesterone的參照價格

第7章 中國國內的Dydrogesterone的主要製造商 (過去5年份)

第8章 中國國內的Dydrogesterone市場的未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境的預測

圖表一覽

目錄
Product Code: 1509313

According to statistics, over 90% of Chinese adult women suffer from different kinds of gynecological conditions to different degrees. And for married urban women, the TOP5 gynecological disorders are genital tract infections (42.9%), menstrual disorder (34.5%), dysmenorrheal (15.5%), pelvic tumor (3.9%) and genital deformity (1.1%). According to Infertility in China, one in eight couples suffers from infertility whose incidence rose from 1-2% in the 1970s to 10-15% in 2014. And it is estimated that 12.5% of women at childbearing age i.e. over 40 million people in China suffer from infertility. 25-37% of infertility is caused by women and over 30% of infertility patients are white collars with high income. According to experts, infertility will become the third health killer after cardiovascular disease and tumor.

As a new generation of progesterone, dydrogesterone of Abbott Biologicals B.V. (Netherland) has been marketed in over 150 countries since its debut in 1961. And it has got the recognition of Chinese obstetricians since it entered China in Apr. 2004.

According to CRI's market survey, dydrogesterone develops fast after entering China with sales value in sample hospitals rising from less than 4 million in 2005 to over 100 million in 2014 and CAGR during this period reaching 50%. Currently, only dydrogesterone of Abbott Biologicals B.V. (Netherland) is available in the Chinese market. As the incidence of gynecological conditions stays high, dydrogesterone enjoys great market potential with its efficacy. Dydrogesterone market in China is expected to grow in future and it is possible that newcomers might appear too.

Readers can get at least the following information through this report:

  • market size of dydrogesterone in China
  • competitive landscape of dydrogesterone market in China
  • price of dydrogesterone made by different enterprises in China
  • market outlook of dydrogesterone in China

The author suggests the following groups of people purchase this report:

  • Pharmaceutical Manufacturers
  • investors/research institutions interested in Chinese medicine market
  • -any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Dydrogesterone

  • 1.1. Indication
  • 1.2. Sales in Global Market

2. Market Profile of Dydrogesterone in China

  • 2.1. Patent and Approval Information of Dydrogesterone in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Dydrogesterone Sales in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Dydrogesterone Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Dydrogesterone in China, 2010-2014

6. Reference Price of Dydrogesterone in Chinese Hospitals in 2014

7. Major Manufacturers of Dydrogesterone in Chinese Market, 2010-2014

8. Market Outlook of Dydrogesterone in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent of Dydrogesterone in China
  • Chart Approval Information of Dydrogesterone in China
  • Chart Dydrogesterone Sales in China
  • Chart Sales Value of Dydrogesterone in China, 2010-2014
  • Chart Sales Value of Dydrogesterone in some Regions in China, 2010-2014
  • Chart Sales Volume of Dydrogesterone in China, 2010-2014
  • Chart Sales Volume of Dydrogesterone in Some Regions in China, 2010-2014
  • Chart Sales Value and Market Share of Dydrogesterone Made by Abbott Biologicals B.V. (Netherland) in China, 2010-2014
  • Chart Market Share of TOP1 Dydrogesterone Manufacturer for Sales Volume in China, 2010-2014
  • Chart Price of Dydrogesterone Made by Abbott Biologicals B.V. (Netherland) in Some Chinese Cities in 2014
Back to Top